Dr. Scott Gottlieb on "Face the Nation with Margaret Brennan," Aug. 23, 2026

Updated on: August 23, 2026 / 2:51 PM EDT / CBS News

Dr. Scott Gottlieb on "Face the Nation with Margaret Brennan," Aug. 23, 2026

TL;DR

  • An experimental mRNA therapeutic for high-risk melanoma is a cancer immunotherapy that trains the immune system to prevent recurrence, not a vaccine against cancer.
  • Recall numbers are not a reliable indicator of the FDA's effectiveness in managing food safety; voluntary recalls are common, and FDA has generally managed outbreaks reasonably well.
  • Dr. Heidi Overton, a potential nominee for FDA commissioner, has a strong policy background but faces scrutiny regarding managerial experience and her stance on vaccines and abortion drugs.
  • Gottlieb believes Overton could be a strong candidate due to her policy expertise and relationships, despite criticisms, and expects her to address concerns during confirmation hearings.